Literature DB >> 2820733

A simplified diagnostic test in hypoparathyroidism and pseudohypoparathyroidism type I with synthetic 1-38 fragment of human parathyroid hormone.

K Kruse1, U Kracht.   

Abstract

Bovine parathyroid extract of E. Lilly (Indianapolis), which has been used to differentiate pseudohypoparathyroidism (PHP) and hypoparathyroidism (HP) is no longer available. We therefore evaluated the usefulness of the synthetic 1-38 fragment of human parathyroid hormone (1-38 hPTH), the biologically active part of the intact hormone, in a simplified modification of the traditional Ellsworth-Howard test. 1-38 hPTH was slowly injected over 2 min at a dose of 0.5 micrograms/kg body weight in healthy children and adults (n = 7), as well as in children with HP (n = 4) and PHP (n = 4). In the controls PTH administration induced a significant rise of plasma cAMP (at least 146 nmol/l), urine cAMP and serum prolactin, as well as a decrease of the tubular phosphate reabsorption. The respective responses were similar in the children with HP but markedly impaired in the patients with PHP. In four healthy adults a second PTH administration at an interval of 3 h induced a comparable response of cAMP and prolactin, indicating that these PTH effects are reproducible and not impaired by the first injection. The two PTH administrations caused a significant but variable rise of serum 1,25-dihydroxy-vitamin D in all four adults. In conclusion 1-38 hPTH has effects on the kidney and anterior pituitary similar to purified parathyroid extracts but has the advantage of being chemically and biologically defined and well tolerated. Since timed urine collections may be unreliable in young children, the plasma cAMP measurement at 5 and 10 min after the PTH injection is a good substitute for the traditional Ellsworth-Howard test, peak values over 100 nmol/l being regarded as a normal response.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2820733     DOI: 10.1007/BF00444941

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  21 in total

1.  The effects of exogenous parathyroid hormone on plasma and urinary adenosine 3', 5'-cyclic monophosphate in man.

Authors:  S Tomlinson; P M Barling; J D Albano; B L Brown; J L O'Riordan
Journal:  Clin Sci Mol Med       Date:  1974-11

2.  Parathyroid function and the renal excretion of 3'5'-adenylic acid.

Authors:  L R Chase; G D Aurbach
Journal:  Proc Natl Acad Sci U S A       Date:  1967-08       Impact factor: 11.205

3.  1,25-Dihydroxyvitamin D production after stimulation with synthetic human parathyroid hormone (1-34) in hypoparathyroid and renal tubular disorders.

Authors:  T Yasuda; H Nakajima
Journal:  Endocrinol Jpn       Date:  1984-08

4.  Effect of parathyroid hormone on plasma prolactin in man.

Authors:  R Isaac; R E Merceron; G Caillens; J P Raymond; R Ardaillou
Journal:  J Clin Endocrinol Metab       Date:  1978-07       Impact factor: 5.958

5.  Plasma cyclic nucleotide determination in the investigation of hypocalcemia.

Authors:  E Mallet; J P Basuyau; P Brunelle; C H de Menibus
Journal:  Pediatr Res       Date:  1979-05       Impact factor: 3.756

6.  Renal 1,25-dihydroxyvitamin D, phosphaturic, and cyclic-AMP responses to intravenous synthetic human parathyroid hormone-(1-34) administration in normal subjects.

Authors:  D M Slovik; M A Daly; J T Potts; R M Neer
Journal:  Clin Endocrinol (Oxf)       Date:  1984-04       Impact factor: 3.478

7.  Renal effects of native parathyroid hormone and synthetic biologically active fragments in pseudohypoparathyroidism and hypoparathyroidism.

Authors:  R M Neer; G W Tregear; J T Potts
Journal:  J Clin Endocrinol Metab       Date:  1977-02       Impact factor: 5.958

8.  Prolactin and calcitonin responses to parathyroid hormone infusion in hypoparathyroid, pseudohypoparathyroid, and normal subjects.

Authors:  A S Brickman; H E Carlson; L J Deftos
Journal:  J Clin Endocrinol Metab       Date:  1981-09       Impact factor: 5.958

9.  Effects of parathyroid hormone on plasma and urinary adenosine 3',5'-monophosphate in man.

Authors:  N I Kaminsky; A E Broadus; J G Hardman; D J Jones; J H Ball; E W Sutherland; G W Liddle
Journal:  J Clin Invest       Date:  1970-12       Impact factor: 14.808

10.  A microassay for 1,25-dihydroxyvitamin D not requiring high performance liquid chromatography: application to clinical studies.

Authors:  T A Reinhardt; R L Horst; J W Orf; B W Hollis
Journal:  J Clin Endocrinol Metab       Date:  1984-01       Impact factor: 5.958

View more
  6 in total

1.  Postnatal establishment of allelic Gαs silencing as a plausible explanation for delayed onset of parathyroid hormone resistance owing to heterozygous Gαs disruption.

Authors:  Serap Turan; Eduardo Fernandez-Rebollo; Cumhur Aydin; Teuta Zoto; Monica Reyes; George Bounoutas; Min Chen; Lee S Weinstein; Reinhold G Erben; Vladimir Marshansky; Murat Bastepe
Journal:  J Bone Miner Res       Date:  2014-03       Impact factor: 6.741

2.  Biochemical markers of bone turnover, intact serum parathyroid horn and renal calcium excretion in patients with pseudohypoparathyroidism and hypoparathyroidism before and during vitamin D treatment.

Authors:  K Kruse; U Kracht; K Wohlfart; U Kruse
Journal:  Eur J Pediatr       Date:  1989-04       Impact factor: 3.183

3.  Paternal and maternal transmission of pseudohypoparathyroidism type Ia in a family with Albright hereditary osteodystrophy: no evidence of genomic imprinting.

Authors:  V Schuster; W Kress; K Kruse
Journal:  J Med Genet       Date:  1994-01       Impact factor: 6.318

4.  [Pseudohypoparathyroidism and adrenal cortex insufficiency. A case of multiple endocrinopathy due to peripheral hormone resistance].

Authors:  P Ridderskamp; R Schlaghecke
Journal:  Klin Wochenschr       Date:  1990-09-14

5.  Endocrine and molecular biological studies in a German family with Albright hereditary osteodystrophy.

Authors:  V Schuster; T Eschenhagen; K Kruse; P Gierschik; H W Kreth
Journal:  Eur J Pediatr       Date:  1993-03       Impact factor: 3.183

6.  Delayed diagnosis of pseudohypoparathyroidism type 1a with rare hypothyroidism since childhood.

Authors:  Ji Eun Jun; So Young Park; In-Kyung Jeong; You-Cheol Hwang; Kyu Jeong Ahn; Ho Yeon Chung
Journal:  Oxf Med Case Reports       Date:  2022-08-18
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.